NCT05955001View on ClinicalTrials.gov

Efficacy of Tadalafil (5mg) For Treatment of Early Storage Symptoms and Erectile Dysfunction After Endoscopic Enucleation of Prostate

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Erectile DysfunctionLower Urinary Tract Symptoms
Interventions
DRUG

Tadalafil 5mg / Placebo

Patients after Holmium laser Enucleation of Prostate (HoLEP) will receive single daily dose of Tadalafil for 3 months and compared to Placebo

Trial Locations (1)

35516

RECRUITING

Urology and Nephrology Center, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER